John W. Martin
Corporate Officer/Principal at The European Commission
John W. Martin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| The European Commission | Corporate Officer/Principal | 24/11/2010 | - |
| University College London | Corporate Officer/Principal | - | - |
Career history of John W. Martin
Former positions of John W. Martin
| Companies | Position | Start | End |
|---|---|---|---|
| United Kingdom Ministry of Home Affairs | Corporate Officer/Principal | 31/12/2005 | 31/12/2005 |
| The European Society of Cardiology | Corporate Officer/Principal | 31/12/2001 | 31/12/2001 |
| Wellcome Research Laboratories | Chief Tech/Sci/R&D Officer | 31/12/1995 | 31/12/1995 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 10/09/2009 | - |
| Founder | 10/09/2009 | - |
Statistics
International
| United Kingdom | 4 |
| Belgium | 2 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Sectoral
| Government | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
| United Kingdom Ministry of Home Affairs | Government |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
| The European Commission | Government |
| Wellcome Research Laboratories | |
| The European Society of Cardiology |
- Stock Market
- Insiders
- John W. Martin
- Experience
